Welcome to BioBOUNCE

A stock market analyzer of volatile BioTech stocks.

BioBounce has a proven track record for correctly predicting the time to purchase a selected biotech stock.

Register for a new account now and get a 14 day free trial.

Member Login

Forgot password or username?

Not a member yet? Sign Up!

Welcome to BioBOUNCE

A stock market analyzer of volatile BioTech stocks.

BioBounce has a proven track record for correctly predicting the time to purchase a selected biotech stock.

Register for a new account now and get a 21 day free trial.

Member Login

Forgot password or username?

Not a member yet? Sign Up!

BioBOUNCE
A long term Biotech portfolio that is actively managed with short term swing trades
BioBounce is a Biotech trading system that combines technical analysis and catalyst driven events.

The system is designed to hold up to 10 full Biotech positions and 5 ETF hedge positions. Because it is impossible to predict which trade will be profitable, the system is best utilized by taking the same position size for each ticker that triggers. Over time the system will build a portfolio.

Once the portfolio is filled with 10 tickers and two of the current holdings hit their target to sell 1/2 the position, one more ticker gets added to the Watchlist.

Trading with us is easy. Here is how it works:

    One ...
    If a Watchlist ticker hits the entry price simply buy the stock.
    Two ...
    Once you purchase the stock or ETF, log into your account nightly and adjust your order to the indicated hard stop. Hard stops are increased as the stock moves higher.
    Three ...
    Everyday at 4:30pm EST, you will receive a daily email indicating what actions you need to take (if any) the following trading day. For example, you may get a notice to sell ticker ABCD at open the next morning (typically before the hard stop is ever hit)
    Four ...
    Once a trade is complete, we add a new ticker to the watchlist and the process starts over.

It is simple. Buy at the indicated price, check your email and follow the recommendations.

Because we provide our entry prices and profit taking targets BEFORE they happen, it is impossible for us to front run our members. Providing the information BEFORE it happens also gives you more time to prepare for the trade. This is especially important for our members that have difficulty trading during the day. Simply set your orders ahead of time and go about your day.

The free trial is No Risk, No Obligation, and No Credit Card Required.
Once your trial ends, you can use the link inside our members area to begin your subscription:
  • $49.99/month.
  • You can cancel at anytime, no questions asked.
  • REGISTER NOW!
Who Are We?
@BioBounce has over 15 years of commercial Biopharmaceutical experience. His knowledge of the biotech industry provides insight to the research side of our selection process.

@AlgoSniffer has been analyzing the stock market for 20+ years. He has developed a unique swing trading method that provides the insight into the technical analysis side of our selection process.

This website combines the expertise of @AlgoSniffer and @BioBounce.

Frequently Asked Questions
"What is included in my membership?"
Up to the minute ticker tracking, email updates with position adjustments, and monthly detailed explanations of the current state of the biotech markets.
"How often does the system place a trade?"
Average is once per month - Several times were in cash for up to 2 weeks - Out of 2 calendar years (365*2) 730 days, we were in a position 416 days of about 57% of the time.
"How do you determine when to take a trade?"
Wouldn't you like to know?
"What is a leveraged ETF?"
A leveraged exchange-traded fund (ETF) is a fund that uses financial derivatives and debt to amplify the returns of an underlying index. Leveraged ETFs are available for most indexes, such as the Nasdaq 100 and the Dow Jones Industrial Average.
"Can you apply your system to other sectors?"
The system can be applied to any ticker.
"What was the max drawdown you experienced trading this system?"
-14.65%
AlgoSniffer, LLC is the Publisher of BioBounce.com and @BioBounceAlerts. AlgoSniffer, LLC is not a Registered Investment Advisor.

BioBounce.com and @BioBounceAlerts are for informational purposes only and AlgoSniffer, LLC accepts no responsibility for any monetary losses incurred from use of the information provided.

Biotechnology is a highly volatile sector, and presents higher than average risk. As a subscriber of our service, you are responsible for your own due diligence regarding any and all tickers we provide on our watchlist.

General Information on the Regulation of Investment Advisers
Division of Investment Management
Exclusions From the Definition
Publishers of bona fide newspapers, news magazines, and business or financial publications of general and regular circulation. Under a decision of the United States Supreme Court, to enable a publisher to qualify for this exclusion, a publication must satisfy three elements: (1) the publication must offer only impersonal advice, i.e., advice not tailored to the individual needs of a specific client, group of clients, or portfolio; (2) the publication must be "bona fide," containing disinterested commentary and analysis rather than promotional material disseminated by someone touting particular securities, advertised lists of stocks "sure to go up," or information distributed as an incident to personalized investment services; and (3) the publication must be of general and regular circulation rather than issued from time to time in response to episodic market activity or events affecting the securities industry. See Lowe v. Securities and Exchange Commission, 472 U.S. 181 (1985).

source: http://www.sec.gov/divisions/investment/iaregulation/memoia.htm